Results 61 to 70 of about 24,438 (192)

Impact of a national donor vigilance system: An example of improved donor health by reduction of delayed bleedings after donor plasmapheresis

Vox Sanguinis, EarlyView.
Abstract Background and Objectives In Denmark, all blood banks use the same standardized donor vigilance system, enabling comparisons of adverse reactions across the country's five regions. At several collection sites, a compression bandage is applied over the venipuncture site after donation.
Pia Braagaard Hartfelt, Christina Mikkelsen, Bitten Aagaard, Rune Larsen, Sys Hasslund, Louise Ørnskov Drechsler, Mark H. Yazer, Mie Topholm Bruun   +7 more
wiley   +1 more source

Use of plasmapheresis in women with placenta isufficiency after IVF

RUDN Journal of Medicine, 2010
The effect of plasmapheresis is studied at placentary insufficiency at 120 women after IVF with placenta isufficiency. The age of investigated women was from 26 to 41 years, average 33,4 ± 4,6 years.
F B Buranova, O V Rogachevskiy
doaj  

Barriers and enablers to non‐remunerated plasma donation: A meta‐synthesis of the qualitative literature using the theoretical domains framework

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Plasma is an essential component of therapies used to treat immune deficiencies, coagulation disorders and other serious conditions. Despite increasing global demand, many countries, including Canada, remain dependent on imported plasma products.
Cole Etherington, Ashutosh Upreti, Amira Brehaut, Megan Bennett, Maximillian Labrecque, Kyle Rubini, Emily Gibson, Manavi T. Maharshi, Amelia Palumbo, Samantha Meyer, Terrie Foster, Joyce Dogba, Risa Shorr, Vivian Welch, Justin Presseau, Elisabeth Vesnaver   +15 more
wiley   +1 more source

Current practices for recruitment and retention of plasma donors across 17 countries: A short report

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Donated plasma is required for the manufacture of plasma medicines, which are essential for prophylaxis and patient treatment. Because of social, geopolitical or economic challenges, this important raw material can become at risk of supply interruption, leading to a lack of essential products for patients.
Marloes L. C. Spekman, Eva‐Maria Merz
wiley   +1 more source

Voluntary non‐remunerated plasma collection in Denmark: Experiences from the Central Denmark Region

Vox Sanguinis, EarlyView.
Abstract Background and Objectives In Denmark, increasing demand for plasma‐derived medicinal products has made plasma self‐sufficiency based on voluntary, non‐remunerated donation a political priority. This report describes recent developments in plasma collection, with a focus on the Central Denmark Region.
Kathrine Agergård Kaspersen, Lotte Hindhede, Sabina Christensen, Cecilie Munck Bjerre, Anne Louise Pørtner, Louise Ørnskov Drechsler, Christina Mikkelsen, Erik Sørensen, Ole Birger Pedersen, Sisse Rye Ostrowski, Betina Samuelsen Sørensen, Bitten Aagaard, Mie Topholm Bruun, Bjarne Kuno Møller, Christian Erikstrup   +14 more
wiley   +1 more source

Mechanisms of haemoglobin mass expansion following heat stress

The Journal of Physiology, EarlyView.
Abstract figure legend Theorised mechanisms of heat stress‐induced erythropoiesis which may facilitate the expansion of haemoglobin mass. A, acute: heat stress‐induced renal ischaemia. Redistribution of blood flow away from the kidneys to facilitate thermoregulation during heat stress could reduce renal oxygen delivery, subsequently lowering renal PO2${
Elliott J. Jenkins, Brittany A. Edgett, Michael G. Hughes, Joshua C. Tremblay, Mike Stembridge   +4 more
wiley   +1 more source

Therapeutic Apheresis for Intravenous Methylprednisolone‐Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single‐Center Case Series

Therapeutic Apheresis and Dialysis, Volume 30, Issue 4, Page 536-543, August 2026.
ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi, Daisuke Katagiri, Takeyuki Watadani, Shunichi Matsuda, Hiroshi Kaneko, Noritoshi Arai   +5 more
wiley   +1 more source

Extracorporeal Methods of Detoxification in Generalized Peritonitis

Общая реаниматология, 2008
Objective: to optimize the results of treatment in patients with generalized peritonitis. Sixty-eight patients were examined. In Group 1 (n=26), plasmapheresis was performed during traditional therapy; in Group 2 (n=28) plasmapheresis was combined with ...
O. M. Shevtsova, N. V. Shapovalova, A. A. Lavrentyev, T. V. Beloshevskaya, V. N. Mishchuk   +4 more
doaj   +1 more source

Pyruvate Kinase M2 Upregulation Is Associated With Guillain–Barré Syndrome Risk and Immune Dysregulation: Insights From Mendelian Randomization and the Experimental Autoimmune Neuritis Model

Brain and Behavior, Volume 16, Issue 8, August 2026.
ABSTRACT Objective This study aimed to investigate the potential involvement of pyruvate kinase M2 (PKM2) in the pathogenesis of Guillain–Barré syndrome (GBS). Methods Mendelian randomization (MR) analysis was used to evaluate the causal association between PKM2 expression and GBS susceptibility, with mediation analysis performed to explore immune cell‐
Shuping Liu, Huiying Lu, Yuge Kang, Zheman Xiao, Qian Min, Yi Dong   +5 more
wiley   +1 more source

A Case Report of Familial Chylomicronemia Syndrome With Infantile Onset: One‐Year Follow‐Up on Lipid Profile and Growth Development

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disease caused by a biallelic loss‐of‐function mutation in the lipoprotein lipase (LPL) gene or its cofactors. This case report describes the diagnosis, management, and one‐year follow‐up of an infant with FCS.
Jinyi Liu, Xuanyu Meng, Yi Wu, Guosheng Huang, Shuheng Liang   +4 more
wiley   +1 more source